• Northfield Laboratories (Evanston, Illinois) reported that Richard Newman, PhD, will assume a leadership role for the company in regulatory affairs. Newman has served as a consultant to Northfield on all aspects of regulatory matters since 2003. Eva Essig, PhD, who previously served in this role, has accepted a regulatory position in the pharmaceutical industry. Northfield Laboratories specializes in oxygen-carrying red blood cell substitute for the treatment of life-threatening blood loss, when an oxygen-carrying fluid is required and red blood cells are not available.

• Mark Forchette was named president/CEO of OptiMedica (Santa Clara, California). Immediately prior to OptiMedica, Forchette led the Alcon vitreoretinal business unit as VP of global marketing and sales. OptiMedica makes ophthalmic technologies focused on improving patient outcomes.